Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02229708 · ClinicalTrials.gov registry record · NA
Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 262
- Enrollment target
NCT02229708: Completed NA study, sponsored by Temple University.
NCT02229708 is a NA study that has completed, run by Temple University. The registered enrollment target is 262 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02229708, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 262 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether a technology-base healthy lifestyle program is an acceptable and effective way for African-American mothers to improve their eating and activity during pregnancy, compared to usual obstetric care. The goal of the program is to enhance the health of African-American mothers and their babies.
Interventions
- BEHAVIORAL Healthy Lifestyle Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-07-17 |
| Phase | NA |
What the finished NCT02229708 record still lists
NCT02229708 is an interventional study that assigns participants to a tested intervention. The registered 262 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Healthy Lifestyle Group is the first listed.
NCT02229708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02229708 about?
NCT02229708 is a clinical study titled "Targeting Pregnancy-related Weight Gain to Reduce Disparities in Obesity". The purpose of this study is to find out whether a technology-base healthy lifestyle program is an acceptable and effective way for African-American mothers to improve their eating and activity during pregnancy, compared to usual obstetric care. The goal of the program is to enhance the health of Af...
What is the current status of trial NCT02229708?
This trial is currently completed. It is a NA study. The enrollment target is 262 participants. The study started on 2014-09. Estimated completion is 2019-07-17.
What interventions are being tested in trial NCT02229708?
The interventions under investigation include: Healthy Lifestyle Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02229708?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02229708's enrollment target sits among peer trials
262 397th of 2000 higher than 1,604 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03713268 · 262 participants
Intraoperative OCT Guidance of Intraocular Surgery II
- NCT06074380 · 262 participants · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
- NCT06293703 · 262 participants · NA
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
- NCT06780137 · 262 participants · Phase 1
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia